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Introduction
Salmonella represents a group of important gram-negative bacterial pathogens that cause intestinal and systemic diseases in human and animal hosts after the ingestion of contaminated water and food such as poultry meat and eggs. 1 Approximately one million cases of Salmonella infections are reported every year in the United States. 2 In previous descriptive studies from different places and samples in Iran, the prevalence of Salmonella was found to be as 9.2% in 272 stool samples and 8% in 369 stool. In a study, 610 samples were obtained from children under 12 years of age with culture-based methods for the detection of Salmonella are sensitive and inexpensive but at the same time they are very time and material-consuming and need initial enrichment. For example, the conventional method for the detection of Salmonellae, including Salmonella Enteritidis, from eggs takes 5-7 days, is labor-intensive and involves the isolation of the organism using pre-enrichment as well as selective enrichment procedures and serological confirmation tests. This method is useful for the detection of small numbers of Salmonella Enteritidis.
Molecular methods (PCR) are good but they also have few limitations. For PCR-based methods, the pathogen needs to be grown and a high concentration of nucleic acid is required to be extracted. 11, 12 Bacterial flagellin is one of the outer membrane proteins that serve many functions like mobility, pathogenicity, and adjuvanticity and shows toll-like receptor (TLR)-ligand activity. It is effective at very low doses 13, 14 and binds to toll-like-receptor 5 (TLR 5), which is present on the immune-system cells (epithelial cells, dendritic cells, and macrophage). One of the outmost flagellin proteins is FliC which has a molecular weight of 50-60 kDa. 15, 16 The binding of FliC with TLR5 leads to a cascade of reactions that results in the production of pro-inflammatory cytokines like TNF-␣, IL-6, and IL-12. 17 In this study, we produced recombinant flagellin (r-FliC) for the detection of Salmonella Enteritidis (SE) using enzyme-linked immunosorbent assay (ELISA) and proposing its usefulness in ELISA for the detection of Salmonella.
Materials and methods

Kits, enzymes, and reagents
The plasmid extraction and gel purification kits were procured from iNtRON (Seongnam, Korea). Nickel-nitrilotriacetic acid (Ni-NTA) agarose was obtained from Qiagen (Maryland, State, USA). Primers were synthesized by Sinaclon (Tehran, Iran). Restriction endonucleases were obtained from Sinaclon (Tehran, Iran). T4 DNA ligase was supplied by Fermentas (Vilnius, Lithuania). All other reagents were of at least analytical grade and obtained from Sigma-Aldrich or Merck, Germany, including kanamycin (40 g/mL, Sigma), nitrocellulose membrane (PROTRAN), anti-polyhistidine antibodies and anti-mouse IgG conjugated with horseradish peroxidase (HRP) (RAY Biotech), and an ELISA reader (Bio-Rad, Berkeley, CA, USA).
Bacterial strains and culture conditions
The standard strain of Salmonella enterica serovar Enteritidis (SE) (ATCC -13076, Institute Pasteur of Iran) was used as the source of flic gene. It was grown in Luria-Bertani (LB) broth or LB agar at 37 • C. Bacterial genome was extracted by the CTABNaCl method, and the DNA concentration was measured by a spectrophotometer (Cecil, UK, OD 260 and 280 nm). The quality of the isolated DNA was assessed by electrophoresis on 1% agarose gel.
Amplification of flic gene
A colony of Salmonella Enteritidis was grown in LuriaBertani broth (LB broth) overnight at 37 • C under constant agitation at 150 rpm. The genomic DNA was extracted from the Salmonella strain and flic gene was amplified by polymerase chain reaction (PCR) using the following two specific primers (flic F: 5-tatagaattcatggcacaagtcattaatac-3 containing an EcoRI-engineered restriction site and flic R: 5-tatataagcttttaacgcagtaaagagagg-3 containing a HindIIIengineered restriction site). The primers were designed to over the complete sequence of flic gene (1518 bp) located on the chromosomal DNA of Salmonella enteritidis as mentioned in the database available at the National Center for Biotechnology Information (NCBI). For the amplification of the flic gene, the polymerase chain reaction (PCR) was standardized using 10 pM of each gene specific primers, 2 L of 25 mM 
Cloning and expression of flagellin
The amplified PCR product was double-digested with EcoRI and HindIII, and cloned into the prokaryotic expression vector pET-28a (+) at EcoRI/HindIII site to form the expression plasmid pET-fliC with kanamycin resistance as a selectable marker. Escherichia coli DH5␣ transformants grown overnight on LB plates containing kanamycin (20 g/mL) were screened. For ligation, the flic gene PCR product and vector plasmid were used in the ratio of 2:1. The ligated product was initially propagated in E. coli DH5␣ competent cells. 15 The transformed colonies were screened by colony PCR, restriction enzyme analysis, and sequencing. The recombinant pET-fliC plasmid extracted from E. coli DH5␣ cells was purified and transformed into E. coli BL21 (DE3) strain for the expression of flagellin. The expression was induced by adding 1 mM isopropyl-␤-d-1-thiogalactopyranoside (IPTG) to growing culture of the transformed E. coli BL21 (DE3) when OD600 reached 0.6, at 37 • C, under constant shaking at 150 rpm. A zero-time aliquot (uninduced culture) was used as the control. The samples were collected after 24 h and analyzed for the protein expression in 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The recombinant protein was further confirmed by Western blot analysis.
Western blot analysis
Western blotting was performed to examine the FliC secretion from E. coli BL21 (DE3). In order to prepare samples, E. coli BL21 (DE3) strain was cultured overnight in LB broth at 37 • C. The cultured bacteria were harvested by centrifugation at 6000 rpm for 15 min. The secreted protein sample was separated on 12% SDS-PAGE. The separated proteins were transferred electrophoretically using transfer buffer (39 mM glycine, 48 mM Tris-base, 0.037% SDS, and 20% methanol, Bio-Rad) onto a polyvinylidene fluoride membrane (PVDF, Immobilon, Millipore) for immunoblotting. The membrane was blocked under constant shaking for 24 h with 5% (w/v) skimmed milk in phosphate-buffered saline (PBS), 0.05% Tween-20 (PBS/T), pH 7.4 at 4 • C. The membrane was incubated with a 1:3000 dilution of mice anti-His-tag specific antibody in the PBS containing 0.05% Tween-20 (PBS/T), with gentle shaking at room temperature for 1 h. After washing the membrane thrice with PBS/T, it was further incubated with goat anti-mouse IgG horseradish peroxidase conjugate, 1:1000 diluted in PBS/T, at room temperature for 1 h and then washed thrice with PBS/T. 3,3 ,5,5 -Tetramethylbenzidine (TMB) substrate was used to visualize the membrane.
Solubility and purification of the recombinant flagellin protein with His-tag
The solubility of the expressed protein was determined by resuspending the bacterial pellet (24 h post IPTG induction) in PBS. After sonication, the lysate was centrifuged at 12,000 × g (15 min) and the supernatant representing the soluble fraction was collected. The pellet containing the insoluble matter was again resuspended in 8 M urea. Both extracts were analyzed by resolving on 12% SDS-PAGE. The poly-His-tag containing recombinant flagellin was purified using nickel divalent ions (Ni-NTA chromatography) (Maryland, USA) under denaturation conditions as per the manufacturer's instructions. The protein concentration was estimated by Bradford's method 18 and the positive elutes confirmed by SDS-PAGE were pooled and stored at −20 • C until future use.
Animal immunization
Female BALB/c mice (18-22 g) used in this study were obtained from Pasteur Institute of Iran, Tehran. The animals were housed and treated in accordance with the Research Ethics Committee according to the Declaration of Helsinki. The mice were divided into test (n = 5) and control groups (n = 3). In the test group, each mouse was injected subcutaneously, at the back of the neck, 10 g of recombinant protein (rFliC) with complete Freund's adjuvant. Subsequently, 10 g of rFliC protein was injected as the first, second, and third booster after 0, 14 and 28 days, using incomplete Freund's adjuvant. The control group was injected with sterile PBS following the same protocol. Blood samples were collected from the mice one week after the second and third booster dose (Table 1) .
Enzyme-linked immunosorbent assay (ELISA) for plasma IgG
Antigen-specific antibody responses were determined by the enzyme-linked immunosorbent assay (ELISA). Polystyrene 8-well plates (MaxiSorp microtiter plates) were coated with 3 g of rFliC diluted in 100 L coating buffer (64 mM Na 2 CO 3 , 136 mM NaHCO 3 , pH 9.8) and then incubated overnight at 4 • C. The plates were washed three times with PBS/T (PBS containing 0.05%, w/v Tween-20). Nonspecific binding sites were blocked with 100 L of 3% (w/v) skimmed milk in PBS/T (1 h, 37 • C). Mouse serum samples were serially diluted to 1:500 in PBS containing 0.03% Tween-20 and were added to the ELISA plates. After three washing steps, 100 L of the goat anti-mouse IgG peroxidase conjugate (Sigma) diluted 1:5000 in PBS/T was added to the plates. The plates were incubated for 1 h at 37 • C and then washed thrice in PBS/T. To each well, 100 L of TMB substrate (Sigma) was added and incubated at room temperature for 15 min. The reaction was stopped with 100 L of 2 M H 2 SO 4 and the result was read by an ELISA reader at the wavelength of 450 nm (Bio-Rad, Berkeley, CA, United States).
Purification of Anti-FliC IgG with Protein G Sepharose 4B column
IgG antibodies were purified using G Sepharose 4B column (Sigma). At first, the column was washed with 100 mM Tris-HCl buffer (pH = 8) followed by 10 mM Tris-HCl buffer (pH = 8) until the column was reached to equilibrium. The serum samples were loaded onto the column and it was washed with 100 mM Tris-HCl buffer (pH = 8) followed by 10 mM Tris-HCl buffer (pH = 8) until all other proteins were eluted. The antibodies were eluted from the column by passing 100 mM glycine buffer (pH = 3). At the end, the purity of IgG was confirmed by SDS-PAGE (12%).
The determination of optimum concentrations of the antibody and bacteria ELISA was performed as described above using the different concentrations of the purified anti-FliC IgG antibody (2, 3, 4, 5, 10, 20, 30, 40, 50 and 60 g) and a constant concentration of the antigen (3 g). In another set of experiment, ELISA was performed with the different concentrations of the antigen (0.625, 1.25, 2.5, 5, 10, 15 and 20 g) and a constant concentration of the antibody (10 g). Subsequent to this, whole-bacterial cell-ELISA was carried out with the standard strain of Salmonella enteritidis according to McFarland standard (OD: 0.257 nm, cell density 3 × 10 8 CFU/mL). In this assay, the plates were coated with the different concentrations of bacterial cells (10 8 , 10 7 , 10 6 , 10 5 , 10 4 , 10 3 , 10 2 , and 10 CFU/mL) and were exposed to a constant concentration (10 g) of the antibody.
Specificity test
The specificity of the indirect-ELISA was checked using a variety of other bacteria, including E. coli, Shigella sp., Pseudomonas aeruginosa, Klebsiella sp., Staphylococcus aureus and Salmonella Enteritidis. The results revealed that ELISA was sensitive only against Salmonella Enteritidis with a detection sensitivity of 10 6 CFU/mL and showed no cross-reactivity with other tested bacterial species. The cut-off was OD 0.7 as determined on the basis of the average control samples plus two-fold standard deviations.
Clinical samples
The infectious dose of Salmonella is 10 6 -10 7 cells. Therefore, the ELISA was performed using clinical specimens collected from the patients with Salmonellosis (20 samples). The assay protocol was based on the previous ELISA, optimized by a standard strain of Salmonella Enteritidis with 10 6 CFU/mL cells.
Statistical analysis
All the data points were the mean (±SD) of three independent sets of experiments. SPSS and Excel software were used to determine means and standard deviations. The results were subjected to Student's t-test (Excel; Microsoft) for independent variables and the values were considered significant at p-values <0.05.
Results
Amplification and cloning of filc gene
Salmonella Enteritidis genome was extracted (Fig. 1A) and the flic gene was amplified by PCR using the specific primers. The PCR product (1500 bp) is shown in Fig. 1B . The fragment was cloned in pET-28a (+) vector and then transformed into E. coli DH5␣. pET28a-flic plasmids were extracted from E. coli and digested by EcoRI/HindIII and analyzed by agarose gel electrophoresis (Fig. 1C) . The recombinant pET28a-fliC plasmid extracted from E. coli DH5␣ cells was purified and transformed to E. coli BL21 (DE3) cells for the expression of FliC protein.
Expression and purification of recombinant protein
The recombinant FliC protein with N-terminal His-tag was expressed in E. coli BL21-DE3 cells ( Fig. 2A) and purified by Ni-NTA affinity chromatography. The SDS-PAGE of the purified product is depicted in Fig. 2B . The Western blotting with the anti-His-tag antibody confirmed the presence of a 55-kDa protein (Fig. 2C) .
Immune response elicited with rFliC
The patterns of antibody production followed by the immunization at three settings of the first, second and third injections were the same except for the increased antibody titer after each phase of the immunization (Fig. 3) . This suggests that the adjuvanted recombinant flagellin injected into the BALB/c mice has good immunogenic properties. The sera obtained from the control mice that were injected with the same preparation without flagellin did not reveal any significant level of the anti-flagellin antibody.
Purification of anti-FliC IgG with Protein G Sepharose 4B column
Anti-FliC IgG was purified with Protein G Sepharose 4B column chromatography and achieved a concentration of 2.339 mg/mL. In the 12% SDS-PAGE, the protein appeared as single band confirming its purity (Fig. 4A) .
The evaluation of the optimum concentrations of antibody and Salmonella Enteritidis for specific ELISA
A specific ELISA was designed with a constant concentration of antigen (3 g) and varying antibody concentrations (2, 3, 4, 5, 10, 20, 30, 40, 50 and 60 g) for the determination of the optimum concentration of antibody. A concentration of 10 g antibody was found to be the optimum (Fig. 4B) . Another ELISA was performed for the determination of antigen with a serially diluted concentration of recombinant flagellin (0.625, 1.25, 2.5, 5, 10, 15 and 20 g) and a constant concentration of antibody (10 g). On the basis of this result, 3 g was considered for antigen coating (Fig. 4C) . For the detection of Salmonella Enteritidis infection, bacterial-ELISA was designed with the standard strain of Salmonella (10 6 CFU/mL cells) (Fig. 4D) .
Specificity test
The specificity of the indirect-ELISA was established using a variety of other microbial strains and showed no crossreactivity with other tested bacteria. Based on the control samples the cut-off was determined to be 0.7 and the ELISA test assayed on 10 6 CFU/mL bacteria. The results of the ELISA are shown in Fig. 5 .
Samples results
The clinical samples were tested with ELISA for the detection of Salmonella antigen. The results of ELISA are shown in Fig. 6 .
Discussion
Non-typhoidal Salmonella enterica serovars cause most of the cases of bacterial food-borne diseases worldwide. Salmonella Enteritidis, which is one of the most common causes of food poisoning in humans, can cause diseases such as gastroenteritis, bacteremia, fever, intestinal, and fecal infection. 19 Over the past decade, a number of investigations have reported an increasing incidence of non-typhoid Salmonella bacteremia. 20 Therefore, a rapid and proper detection of this bacterium is important for food safety. The bacterial culture based methods for the identification of Salmonella are time-consuming (5-7 days) and require enrichment of the culture. 21 As such, several screening methods such as nucleic acid-based assays and immunology-based assays have been examined for a rapid detection of Salmonella in the recent decades. 20, [22] [23] [24] In earlier studies, lipopolysaccharides (LPS) present on the bacterial surface were used in the ELISA-assay for the detection of Salmonella, but the problem with lipopolysaccharides is the cross-reactivity with other gram-negative bacteria. [25] [26] [27] Therefore, flagellin (FliC) was sought as an alternative for rapid diagnosis of Salmonella and, during the last decade, several studies have used it for the detection of Salmonella. For the production of recombinant FliC (rFlic), in this study, a standard strain of Salmonella enterica serovar Enteritidis was used that produces an antigen with high immunogenicity. 28 A DNA fragment of the expected size (near 1518 bp) was amplified by PCR and expressed using chemically inducible T7 promoter (pET28a). The best condition for the recombinant rFliC expression was achieved at 1 mM IPTG concentration, the culture temperature of 37 • C and with overnight induction. However, the protein expression showed an increase with the incubation time up to 18 h. rFliC was separated on SDS-PAGE and its biochemical nature was confirmed by immunoblotting using mice anti-His-tag specific antibody. rFliC was purified based on 6XHis-tag using the Ni-NTA column. The purified rFliC was used for the immunization of mice. The ELISA test results showed that all immunized mice produced a high titer of anti-FliC antibody upon injecting rFliC three times. Then an ELISA system was designed for the detection of Salmonella Enteritidis, which is an important pathogen of human and poultry. Accurate and quick tests are essential to ensure food safety by the governments. 29 The availability of sufficient quantities of recombinant antigens for the rapid detection of Salmonella can be achieved in serum samples in a short time. 30 Thus, new methods for quick detection of Salmonella have been developed in the past decade. Among the molecular techniques, PCR is a common and accurate method and can also be used for the detection of low levels of pathogenic bacteria. 31 ELISA can be used to screen a variety of samples and components in the presence of Salmonella spp. The ELISA test, designed in this study, did not show any cross-reaction with other bacteria. Sensitivity analysis of this test showed that it could detect 10 3 bacteria in clinical samples, given that the infectious dose of Salmonella is about 10 6 approximately.
Besides ours, the studies of Minicozzi (2013), 5 Jindal (2012) 13 and Bang (2012) 21 have also reported the production of recombinant flagellar antigen (r-FliC) and development of ELISA for the detection of Salmonella. In previous works, the investigations were carried out mainly with sera obtained from infected flocks and birds but, in this study, we used mice for the production of antibody and Protein G Sepharose 4B column for the purification. The flic gene of Salmonella Enteritidis was amplified, cloned successfully using pET-28a(+) expression vector and was introduced into E. coli BL21 (DE3) as a suitable host. The recombinant flagellin was purified successfully and demonstrated good immunogenic properties based on the immunization of BALB/c mice and its ability to induce a significant serum flagellin-specific IgG immune response, which was measured by ELISA. We provide further evidence that the recombinant flagellin can be one of the excellent indicators for the detection of Salmonella Enteritidis.
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